Last reviewed · How we verify
iv infusion of [14C]-OZ439
iv infusion of [14C]-OZ439 is a Small molecule drug developed by Medicines for Malaria Venture. It is currently in Phase 1 development.
At a glance
| Generic name | iv infusion of [14C]-OZ439 |
|---|---|
| Sponsor | Medicines for Malaria Venture |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- iv infusion of [14C]-OZ439 CI brief — competitive landscape report
- iv infusion of [14C]-OZ439 updates RSS · CI watch RSS
- Medicines for Malaria Venture portfolio CI
Frequently asked questions about iv infusion of [14C]-OZ439
What is iv infusion of [14C]-OZ439?
iv infusion of [14C]-OZ439 is a Small molecule drug developed by Medicines for Malaria Venture.
Who makes iv infusion of [14C]-OZ439?
iv infusion of [14C]-OZ439 is developed by Medicines for Malaria Venture (see full Medicines for Malaria Venture pipeline at /company/medicines-for-malaria-venture).
What development phase is iv infusion of [14C]-OZ439 in?
iv infusion of [14C]-OZ439 is in Phase 1.